Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients
NCT: NCT03024112 · COMPLETED
Brief Summary
The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.
Frequently Asked Questions
What is Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients?
Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients is a clinical trial registered under NCT03024112. Current status: COMPLETED.
What is the status of NCT03024112?
The current status of NCT03024112 (Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients) is: COMPLETED.
When did Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients start?
Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients started on 2013-08.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.